P

Inventor

MACIELAG MARK

US34 patents
⚠️ This page may combine multiple inventors who share the name “MACIELAG MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

24 patents
US8741887B2Jun 3, 2014

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV49 citations98
US8697684B2Apr 15, 2014

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV48 citations98
US8604017B2Dec 10, 2013

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV49 citations98
US10428134B2Oct 1, 2019

Immunoglobulins and uses thereof

JANSSEN PHARMACEUTICA NV7 citations92
US8367653B2Feb 5, 2013

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV8 citations92
US10968264B2Apr 6, 2021

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV2 citations84
US8362000B2Jan 29, 2013

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV6 citations84
US11767354B2Sep 26, 2023

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV3 citations83
US11591379B2Feb 28, 2023

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV3 citations83
US11401315B2Aug 2, 2022

Immunoglobulins and uses thereof

JANSSEN PHARMACEUTICA NV2 citations83
US10968265B2Apr 6, 2021

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV4 citations83
US10858413B2Dec 8, 2020

Immunoglobulins and uses thereof

JANSSEN PHARMACEUTICA NV3 citations83
US10787495B2Sep 29, 2020

Immunoglobulins and uses thereof

JANSSEN PHARMACEUTICA NV3 citations83
US10640544B2May 5, 2020

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV4 citations83
US8722658B2May 13, 2014

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV2 citations74
US8691805B2Apr 8, 2014

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV2 citations74
US8623858B2Jan 7, 2014

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV2 citations74
US8362001B2Jan 29, 2013

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV4 citations74
US10961293B2Mar 30, 2021

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV2 citations73
US12134636B2Nov 5, 2024

Immunoglobulins and uses thereof

JANSSEN PHARMACEUTICA NV0 citations72
US9464055B2Oct 11, 2016

Quinoline derivatives useful as CB-1 inverse agonists

JANSSEN PHARMACEUTICA NV3 citations72
US8962607B2Feb 24, 2015

Azetidinyl diamides as monoacylglycerol lipase inhibitors

JANSSEN PHARMACEUTICA NV2 citations72
US11732019B2Aug 22, 2023

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

JANSSEN PHARMACEUTICA NV0 citations62
US9266835B2Feb 23, 2016

Quinoline derivatives useful as CB-1 inverse agonists

JANSSEN PHARMACEUTICA NV2 citations51

BIAN HAIYAN

5 patents

ORTHO MCNEIL PHARM INC

4 patents

CHEVALIER KRISTEN

1 patent